Incidence and predictors of implantable cardioverter-defibrillator therapy and its complications in idiopathic ventricular fibrillation patients.
Blom LJ, Visser M, Christiaans I, Scholten MF, Bootsma M, van den Berg MP, Yap SC, van der Heijden JF, Doevendans PA, Loh P, Postema PG, Barge-Schaapsveld DQ, Hofman N, Volders PGA, Wilde AA, Hassink RJ.
Blom LJ, et al. Among authors: christiaans i.
Europace. 2019 Oct 1;21(10):1519-1526. doi: 10.1093/europace/euz151.
Europace. 2019.
PMID: 31114860